A Maryland bill that would make the state a national test case for controlling prescription drug costs has garnered broad legislative support in Annapolis but could put the state on a legal collision course with the pharmaceutical industry.
The Inova Personalized Health Accelerator (IPHA) announced today that it will expand its free educational program designed to teach first-time healthcare technology entrepreneurs how to grow successful companies. The spring 2018 session will build on the curriculum provided during the fall 2017 program. Inova’s fall program supported 57 enrolled participants over a 14-week training period. Entrepreneurs interested in participating in the program are encouraged to apply via the IPHA web site (http://www.inovapha.org/for-entrepreneurs/training-program/ )
Researchers from theUniversity of Maryland School of Medicine (UMSOM) and the University of Maryland A. James Clark School of Engineering have developed a new military vehicle shock absorbing device that may protect troops from traumatic brain injury (TBI) after a land mine blast. Over the past 18 years of conflicts in Iraq and Afghanistan, more than 250,000 troops have suffered such injuries.
When: Wednesday, March 14, 2018 from 5:00 PM to 7:00 PM
Where: Bar Louie 150 Gibbs St Rockville, MD 20850
Join BioBuzz and founding sponsor The Johns Hopkins University Montgomery County Campus at Bar Louie on March 14th. The Johns Hopkins University Montgomery County Campus offers part-time graduate courses in biotechnology fields. Students attend classes in the evenings and on Saturdays, enabling them to hold full-time jobs during the day. Depending on the degree area, students can fully complete their coursework in Montgomery County. Other students take some courses in Baltimore and/ or online.
MIMETAS, the market leader in Organ-on-a-chip products, announced that the National Cancer Institute recently awarded them a phase 1 SBIR grant totally $300,000 to develop personalized prostate cancer-on-a-chip models that can more accurately reproduce the tumor micro-environment. MIMETAS has built a consortium with the University of Texas Health Science Center (UTHSC) and MD Anderson to build the next generation platform for cancer drug screening and personal therapy prediction.
The University of Maryland’s SGA will send a letter to Amazon supporting Montgomery County for the company’s second headquarters, called HQ2.
MedImmune Inc., the research and development arm of global drug giant AstraZeneca PLC, is spinning out a new company named Viela Bio with plans to create 100 jobs within the next three to five years.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
New BioHealth event free to attend with excellent speakers and no registration required
Sponsored by Montgomery County Councilmember George Leventhal
Wednesday, February 28, 7-9pm at Johns Hopkins University Montgomery County Campus
Moderator:
Richard A. Bendis, President and CEO BioHealth Innovation Inc.
Panelists:
Jarrod Borkat, Senior Director, External Partnerships & Collaborations, MedImmune
Dr. Chris Austin, Director National Center for Advancing Translational Sciences (NCATS), Nation Institutes of Health
Anthony Saleh, PhD, Founder & CEO, Mirecule
150 post docs from the National Cancer Institute (NCI) and other institutes at NIH had the opportunity to meet BioHealth Capital Region industry leaders and discuss possible career paths in the private sector at two different events this month. The events, co-hosted by BioHealth Innovation, WorkSource Montgomery, SciPhd and BioBuzz, were held in conjunction with SciPhd workshops hosted at NIH’s main campus and at the NCI campus in Rockville which are focused on training scientists for professional careers. BioHealth Innovation is working with local partners to support the growth of the region’s biohealth industry talent pool with entrepreneurial and commercially relevant experience.